Search for: "Janssen Ortho, Inc."
Results 21 - 40
of 110
Sorted by Relevance
|
Sort by Date
25 Jan 2010, 8:42 pm
The United States filed a qui tam or False Claims Act complaint against Johnson & Johnson (J&J) and its subsidiary companies Johnson & Johnson Health Care Systems Inc. and Ortho-McNeil-Janssen Pharmaceuticals Inc. [read post]
16 Mar 2011, 4:29 am
Stearns of the District of Massachusetts entered an order in the consolidated cases against Johnson & Johnson and its subsidiaries (Ortho-McNeil-Janssen Pharm. and Johnson & Johnson Health Care Systems, Inc.) for allegedly paying kickbacks to the long-term care pharmacy chain Omnicare. [read post]
18 Apr 2011, 12:40 pm
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side effects like… [read post]
8 Aug 2011, 12:53 pm
A South Carolina judge has ordered Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit to pay the state of South Carolina $327 million for deceptive marketing of their anti-psychotic drug, Risperdal. [read post]
4 Dec 2012, 6:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
30 Dec 2012, 3:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
19 Mar 2014, 9:00 am
Instead Janssen only challenged the methodology of Abbott’s tests. [read post]
11 Aug 2011, 7:58 am
Ortho-McNeil-Janssen Pharmaceuticals Inc. [read post]
26 Jun 2013, 6:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
1 Mar 2013, 6:28 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
31 Jan 2013, 7:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
24 Oct 2014, 7:56 am
Janssen Pharmaceuticals, Inc., No. 3:12-oe-40003, 2014 U.S. [read post]
29 Apr 2010, 1:26 pm
Johnson & Johnson and Ortho-McNeil Pharmaceutical, Inc., Civil Action No. 04-11886-WGY. [read post]
29 Apr 2010, 1:26 pm
Johnson & Johnson and Ortho-McNeil Pharmaceutical, Inc., Civil Action No. 04-11886-WGY. [read post]
2 Sep 2020, 1:45 pm
JOHNSON & JOHNSON d/b/a Alza Corporation, d/b/a Janssen Ortho LLC, d/b/a Janssen Research & Development LLC, d/b/a Ortho-McNeil Pharmaceuticals, Inc. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
21 Jun 2011, 6:00 am
Ortho-McNeil-Janssen Pharmaceuticals Inc. announced that the lot of about 16,000 bottles of 3-milligram Risperdal tablets was shipped out anywhere from August, 2010 and February, 2011. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
11 Dec 2015, 8:53 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 15-3104, slip op. (6th Cir. [read post]
